Recombinant DNA technology is a set of lab methods that cut a gene out of one organism’s DNA with restriction enzymes, join it into a carrier DNA (a vector, usually a plasmid) with DNA ligase, and put it into a host cell such as E. coli or yeast. The host then copies the gene or uses it to make a protein, such as human insulin.
Last updated October 2026 · Written by Dr Nidhi Joshi
Every living thing runs on DNA, the instruction manual inside each cell. Recombinant DNA technology lets scientists take a useful piece of that manual from one organism and place it into another, where it can be copied or read. So the DNA molecule this produces is called recombinant DNA, or rDNA. The technique is the foundation of modern biotechnology and of genetic engineering.
WHAT IS RECOMBINANT DNA TECHNOLOGY?
Recombinant DNA technology is a set of laboratory methods that use enzymes to cut, join and copy chosen DNA segments. The U.S. National Human Genome Research Institute describes it as a way to combine DNA from different species, or to create genes with new functions, and then grow that DNA inside a bacterial or yeast cell that copies it along with its own genome.
Put simply, it is “cut, paste and copy” for genes. Crossing-over during meiosis also mixes DNA naturally, but in biotechnology the word recombinant usually means DNA joined in the lab from two different sources.
WHAT IS A RECOMBINANT DNA MOLECULE?
A recombinant DNA molecule has two parts. The first is the gene of interest (often called the insert), for example the human insulin gene. The second is a vector, a carrier DNA that can copy itself inside a host cell. When the insert is placed inside the vector, the combined molecule is recombinant DNA. Also, a gene that sits in this new setting is often called a recombinant gene.
THE TOOLS: ENZYMES, VECTORS AND HOST CELLS
Three kinds of tools make the method work:
- Restriction enzymes act as molecular scissors. Each one cuts DNA at a specific short sequence and often leaves “sticky ends” that can pair up with matching ends.
- DNA ligase is the molecular glue. It seals the insert into the vector permanently.
- Vectors and hosts. For example, plasmids, the small rings of DNA found in bacteria, are the classic vectors. Modified viruses are also used. The host is usually E. coli or yeast, because both grow quickly and cheaply.
HOW RECOMBINANT DNA IS MADE: 5 STEPS
- Isolate the DNA. Extract DNA that contains the gene you want, and purify a plasmid vector.
- Cut. Use the same restriction enzyme on both, so their ends match.
- Join. Next, mix the insert with the opened plasmid and let DNA ligase seal them together into a recombinant molecule.
- Transform. Introduce the recombinant plasmids into host cells. Usually only one plasmid enters any one cell.
- Select and grow. Grow the cells on a selective medium, such as one containing an antibiotic, so that only cells carrying the plasmid survive. Then, each surviving cell divides into a colony of millions of identical cells, all carrying the same insert.
RECOMBINANT DNA VS GENE CLONING
However, the two terms are closely linked but not identical. Recombinant DNA is the molecule, the gene joined to a vector. Gene cloning (or DNA cloning) is the process of putting that molecule into cells and letting them make many identical copies. Recombinant DNA cloning is therefore the usual route to isolating a single gene in large amounts, so it can be studied, sequenced or used to make a protein.
| Recombinant DNA | Gene cloning | |
|---|---|---|
| What it is | A molecule: gene of interest + vector | A process: copying that molecule in host cells |
| Key tools | Restriction enzymes, DNA ligase, vector | Host cells, selective media, cell growth |
| Output | One joined DNA molecule | Millions of identical copies (a clone) |
Recombinant DNA is the toolkit behind modern genetic engineering. However, it differs from newer approaches. mRNA vaccines, for example, skip the bacterial factory entirely and let your own cells make the protein.
A SHORT HISTORY: FROM 1973 TO HUMAN INSULIN
In 1973, Stanley Cohen, Annie Chang, Herbert Boyer and Robert Helling published a paper in PNAS. They showed that plasmid DNA cut with a restriction enzyme could be rejoined in the test tube, put into E. coli, and copied as a working new plasmid. Then, within months, the same groups showed that genes from unrelated species, and even from animal cells, could be cloned in bacteria. In short, those experiments launched both DNA cloning and the biotechnology industry.
The first big medical payoff was human insulin. Before then, insulin came from cow and pig pancreases. According to the FDA, by 1981 one pound of insulin needed glands from about 23,500 animals. So scientists at Genentech and City of Hope used recombinant DNA to make E. coli produce human insulin. Finally, on 28 October 1982 the FDA approved Humulin, the first medical product of any kind made with this technology.
Recombinant insulin then went through the same stages of drug development as any new medicine.
RECOMBINANT DNA EXAMPLES IN REAL LIFE
Recombinant DNA is far more common than most people realise. For example, well-known uses include:
- Human insulin, for diabetes, made by bacteria or yeast.
- Human growth hormone, which replaced hormone taken from human pituitary glands.
- Hepatitis B vaccine, in which yeast makes a single viral surface protein, so no live virus is needed. See our guide to recombinant and subunit vaccines.
- Blood-clotting factors for haemophilia, and many antibody medicines.
- Industrial enzymes, such as chymosin for cheese-making and enzymes used in detergents.
- Genetically modified crops, such as insect-resistant or herbicide-tolerant plants.
- Research tools: almost every lab that studies a gene or a protein begins by cloning it. Read more about how proteins work.
Related: Insulin and growth hormone are both peptide hormones, which is why bacteria and yeast can make them from a single human gene. See the types of hormones and their functions for how peptide, steroid and amine hormones differ.
RECOMBINANT DNA AND GENE THERAPY
Gene therapy is one of the newest uses of recombinant DNA. The FDA describes gene therapy as modifying a person’s genes to treat or cure disease. Also, it can work by replacing a faulty gene with a healthy copy, switching off a harmful gene, or adding a new gene. So the delivery vehicles are themselves recombinant DNA: engineered plasmids, or viral vectors whose disease-causing genes have been removed. Also, in some therapies, a patient’s own cells are modified outside the body and then returned to them.
BENEFITS AND CONCERNS
In short, the benefits are a safe and plentiful supply of human proteins, cheaper medicines, faster research, and crops that need fewer pesticides. However, the concerns, raised since the 1970s, include laboratory safety, environmental effects of modified organisms, fair access to costly therapies, and ethical limits on editing human germline cells. Today, strict biosafety rules and regulatory review govern recombinant DNA work.
KEY TAKEAWAYS
- Recombinant DNA (rDNA) is DNA joined in the lab from two different sources: a gene plus a vector.
- The core tools are restriction enzymes, DNA ligase, a plasmid or viral vector, and a host cell.
- In short, the basic process is isolate, cut, join, transform, select and grow.
- Real examples include insulin, growth hormone, the hepatitis B vaccine, clotting factors and GM crops.
- Also, gene therapy uses recombinant vectors to deliver working genes into human cells.
Disclaimer: This article is for general educational purposes only and is not medical advice. Medicines, vaccines and gene therapies mentioned here should only be used under the guidance of a qualified healthcare professional.
Related: restriction enzymes and DNA ligase are the cut-and-paste tools of cloning — more in what enzymes are made of.
FREQUENTLY ASKED QUESTIONS
What is recombinant DNA in simple words?
It is DNA made by joining a piece of DNA from one source, such as a human gene, to DNA from another source, such as a bacterial plasmid, so the gene can be copied or used to make a protein.
What are 3 examples of recombinant DNA technology?
Human insulin made in bacteria, the hepatitis B vaccine made in yeast, and insect-resistant GM crops.
What is the difference between recombinant DNA and gene cloning?
Recombinant DNA is the joined molecule. Gene cloning is the process of copying that molecule in host cells to get many identical copies.
What is a recombinant gene?
A recombinant gene is a gene that has been moved into a new DNA setting, usually a vector, so it can be copied or expressed in a different organism.
Which enzymes are used in recombinant DNA technology?
Mainly restriction enzymes, which cut DNA at specific sites, and DNA ligase, which joins the pieces. Polymerases are used to copy DNA, for example in PCR.
Is recombinant DNA used in gene therapy?
Yes. Gene therapies use engineered plasmids or modified viral vectors to carry therapeutic genes into a patient’s cells.
Who discovered recombinant DNA technology?
Stanley Cohen and Herbert Boyer, with colleagues, published the first recombinant plasmids made in the lab in 1973. Paul Berg’s earlier work joining viral DNA also paved the way.
SOURCES
- National Human Genome Research Institute. Recombinant DNA Technology (Genetics Glossary). https://www.genome.gov/genetics-glossary/Recombinant-DNA
- Cohen SN, Chang ACY, Boyer HW, Helling RB. Construction of Biologically Functional Bacterial Plasmids In Vitro. PNAS, 1973. https://pmc.ncbi.nlm.nih.gov/articles/PMC427208/
- Cohen SN. DNA cloning: A personal view after 40 years. PNAS, 2013. https://pmc.ncbi.nlm.nih.gov/articles/PMC3785787/
- U.S. Food and Drug Administration. 100 Years of Insulin. https://www.fda.gov/about-fda/fda-history-exhibits/100-years-insulin
- U.S. Food and Drug Administration. What is Gene Therapy? https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/what-gene-therapy